Research Grant
[Cite as https://purl.org/au-research/grants/nhmrc/1093062]Researchers: Prof Philip Thompson (Principal investigator)
Brief description Inhibitors of the PI3 kinase family of enzymes have potential as therapeutics in diseases such as cancer, thrombosis and inflammatory disease. In this project the investigators will develop a new class of PI3 kinase inhibitors they have discovered, optimizing their pharmaceutical properties and evaluating them in models of disease. The aim is to develop a candidate for human clinical studies.
Funding Amount $AUD 474,473.37
Funding Scheme Development Grants
Notes Development Grant
- nhmrc : 1093062
- PURL : https://purl.org/au-research/grants/nhmrc/1093062
